Top Markets
#1 Black Phoenix Black Phoenix +831.35%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +29.79%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.50%
#4 Beam Beam +26.38%
#5 SAFEcoin SAFEcoin +20.76%
#6 Magma Finance Magma Finance +20.25%
#7 pipedog pipedog +19.56%
#8 PondCoin PondCoin +18.82%
#9 THORChain THORChain +16.58%
#10 Bless Bless +16.25%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Rang in Aktien #6153
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Aktienkurs
$156.13
Marktkapitalisierung
$2.24B
Veränderung (1 Tag)
1.17%
Veränderung (1 Jahr)
176.58%
Land
US
Handel Palvella Therapeutics, Inc. (PVLA)

Kategorie

Healthcare
Kursverlauf für Palvella Therapeutics, Inc. (PVLA)
Höchster Schlusskurs: $151.75 am 2026-08-01

Niedrigster Schlusskurs: $13.11 am 2024-12-01
Kursverlauf der Aktie von Palvella Therapeutics, Inc. von 2024 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 7.49%
2025 649.84%
2024 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.14 40.88%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.84%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $142.44 467.49%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH